Analysis of Acute Fever Reaction in Postmenopausal Women with Zoledronic Acid Treatment for Osteoporosis

杨毅,李蓬秋,鲜杨,张学军,包明晶,张磊,杨艳,朱显军,曹旭,刘丽梅

DOI: https://doi.org/10.3969/j.issn.1006-7108.2013.01.015

2013-01-01

Abstract:Objective To analyze the incidence of acute fever reaction after the treatment of intravenous zoledronic acid in postmenopausal women with osteoporosis,and to identify the related factors.Methods Clinical data of 63 postmenopausal women with osteoporosis,who were treated with intravenous infusion of 5mg zoledronic acid from June 2010 to April 2012,were analyzed retrospectively.The incidence of acute fever reaction in these patients was observed.All the patients were divided into fever group and non-fever group according to whether having fever symptoms or not.The age,severity of osteoporosis before zoledronic acid treatment,variations of parathyroid hormone and serum calcium,and the use of anti-osteoporosis drugs before the treatment were compared between the 2 groups.Results Twenty-one patients had acute fever reaction(33.3%).Among these 21 patients,71% patients(15/21) had fever on the day of zoledronic acid treatment,and the other patients had fever on the first day after the treatment.The fever lasted for 1 day in 66.7% of the patients(14/21),and for 2 days in 5 patients.The average temperature was 38.8±0.5 C.The patients with fever had higher parathyroid hormone level before treatment than those without fever(P0.05).Serum calcium and bone mineral density showed no significant difference between the 2 groups.Conclusion Acute fever reaction is not rare in postmenopausal patients receiving intravenous zoledronic acid for the treatment of osteoporosis,but it is transient.Parathyroid hormone level before the treatment is associated with the fever.